However, according to Ozempics prescribing label, the drug has the potential to interfere with the absorption of oral medications (medications taken by mouth) because it slows the stomachs emptying
13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [2-, 11-, and 30-fold the maximum recommended human dose (MRHD) of 2 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (1-, 2-, and 7-fold MRHD) were administered to the females
Further studies are needed here, but it has the potential as a treatment for obesity and diabetes.[ref] EGCG: Found in green tea, EGCG has been shown in cell studies to increase GLP-1 secretion.[ref] Yerba mate tea: Animal studies show that Yerba mate induces GLP-1 secretion.[ref] Increase bitterness: The TAS2R38 gene, a bitter taste receptor, is active in the same cells in the gastrointestinal tract as glucagon-like peptide 1 cells
Peak severity: Months 4 to 8
Wegovy (semaglutide) typically has a U.S